An Italian man has become the first person in the world to test positive for COVID-19, monkeypox and HIV in a single day.
According to a case study in the Journal of Infection, the unidentified 36-year-old man first developed fever, sore throat and headache nine days after returning from a trip to Spain, where he had unprotected sex with other men.
The study says he first tested positive for COVID-19 on July 2 — then within hours began to develop a rash and “small, painful” blisters around his body, legs, face and butt.


He went to an ER, and the other day there again tested positive for COVID-19 – as well as monkeypox.
The study said that on the same day, July 6, they also learned that they had HIV despite having tested negative for the last time in September.
“As this is the only reported case of monkeypox virus, SARS-CoV-2 and HIV co-infection, there is still not enough evidence to support that this combination may increase. [a] patient condition,” he wrote.
The researchers said that “the case emphasizes that sexual intercourse may be the predominant mode of transmission of monkeypox”.
“Therefore, complete [sexually transmitted infection] Screening is recommended after a diagnosis of monkeypox.
“In fact, our patient tested positive for HIV-1 and, given his preserved CD4 count, we can assume that the infection was relatively recent,” he said of the patient, who had previously been diagnosed with syphilis. Was also.
Although this is the first known case of its kind, given the rapid spread of monkeypox, more than 45,000 cases are likely to be reported in 98 countries.
“The majority of cases were reported in gay or bisexual men who often suffer from other STIs”, he said.
“As these pathogens continue to spread, individuals can become simultaneously infected with the monkeypox virus, SARS-CoV-2, and STIs, making it difficult for physicians to make an accurate diagnosis,” he said, noting how similar share symptoms.
“Health care systems should be aware of this phenomenon, promoting appropriate clinical trials in high-risk subjects, which are essential for prevention as there is no widely available treatment,” they wrote.
(This story has not been edited by seemayo staff and is published from a rss feed)
